Entrada Therapeutics Inc.

2 trials 2 recruiting Commercial sponsor

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

4 Countries active

3 Unique IMPs

N/A Results reported

Phase I/II

Phase I (FiH)

Phase I/II: 1 Phase I (FiH): 1

Oversight events:

2 corrective measures across 2 trials

View oversight register →

Top indications

Duchenne muscular dystrophy 2 Duchenne muscular dystrophy gene carrier 2

Top IMPs

ENTR-601-44 1 ENTR-601-45 1

All trials

2 total

A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping t… Recruiting

2024-517499-39-00 Phase I (FiH) 4 countries ENTR-601-45
A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping t… Recruiting

2024-517584-23-00 Phase I/II 3 countries ENTR-601-44

Showing 1–2 of 2 trials

← All sponsors A–Z